Breast adenomyoepithelioma and adenomyoepithelioma with carcinoma (malignant adenomyoepithelioma) with associated breast malignancies: A case series emphasizing histologic, radiologic, and clinical correlation

August W. Moritz, James F. Wiedenhoefer, Amanda P. Profit, Jaishree Jagirdar

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The 2012 World Health Organization (WHO) classification of breast tumors distinguishes adenomyoepitheliomas (AMEs) as benign tumors composed of a biphasic proliferation of phenotypically variable myoepithelial cells around small epithelial lined spaces. Many AMEs have demonstrated benign behavior and are often cured with excision with negative margins, but some have exhibited malignant transformation of the myoepithelial cells, ductal epithelial cells, or both. When one of the components is histologically malignant, it is termed AME with carcinoma. Due to the rarity, the literature correlating imaging, histology, and clinical outcome is limited. A retrospective review was undertaken. A review of an institutional pathology database identified 14 cases with AME or malignant AME. Most AMEs had nonspecific imaging findings and were categorized as Bi-Rads 4. Histologic features of AME did not correlate with prior or concurrent breast malignancies or any radiographic features. Clinical follow up could be obtained for all but one case (mean follow up time = 75 months). 5 cases had no known treatment post-biopsy and 5 patients received mastectomy. No recurrences were noted. 3/13 cases of benign AME had associated breast malignancies including invasive ductal adenocarcinoma and ductal carcinoma in-situ. 1 case of malignant AME had a synchronous separate malignant phyllodes tumor. Given the unclear and unpredictable propensity for malignant transformation, conservative excision with negative margins currently seems appropriate.

Original languageEnglish (US)
Pages (from-to)132-139
Number of pages8
JournalBreast
Volume29
DOIs
StatePublished - Oct 1 2016

Fingerprint

Adenomyoepithelioma
Breast
Carcinoma
Phyllodes Tumor
Neoplasms
Carcinoma, Intraductal, Noninfiltrating
Mastectomy
Histology
Adenocarcinoma
Epithelial Cells
Databases
Pathology
Breast Neoplasms
Biopsy
Recurrence
Therapeutics

Keywords

  • Adenomyoepithelioma
  • Adenomyoepithelioma with carcinoma
  • AME
  • Malignant adenomyoepithelioma
  • Malignant transformation of adenomyoepithelioma
  • Radiology of adenomyoepithelioma

ASJC Scopus subject areas

  • Surgery

Cite this

Breast adenomyoepithelioma and adenomyoepithelioma with carcinoma (malignant adenomyoepithelioma) with associated breast malignancies : A case series emphasizing histologic, radiologic, and clinical correlation. / Moritz, August W.; Wiedenhoefer, James F.; Profit, Amanda P.; Jagirdar, Jaishree.

In: Breast, Vol. 29, 01.10.2016, p. 132-139.

Research output: Contribution to journalArticle

@article{c1c9bf07b56c4608a3982faf9a5bf3fa,
title = "Breast adenomyoepithelioma and adenomyoepithelioma with carcinoma (malignant adenomyoepithelioma) with associated breast malignancies: A case series emphasizing histologic, radiologic, and clinical correlation",
abstract = "The 2012 World Health Organization (WHO) classification of breast tumors distinguishes adenomyoepitheliomas (AMEs) as benign tumors composed of a biphasic proliferation of phenotypically variable myoepithelial cells around small epithelial lined spaces. Many AMEs have demonstrated benign behavior and are often cured with excision with negative margins, but some have exhibited malignant transformation of the myoepithelial cells, ductal epithelial cells, or both. When one of the components is histologically malignant, it is termed AME with carcinoma. Due to the rarity, the literature correlating imaging, histology, and clinical outcome is limited. A retrospective review was undertaken. A review of an institutional pathology database identified 14 cases with AME or malignant AME. Most AMEs had nonspecific imaging findings and were categorized as Bi-Rads 4. Histologic features of AME did not correlate with prior or concurrent breast malignancies or any radiographic features. Clinical follow up could be obtained for all but one case (mean follow up time = 75 months). 5 cases had no known treatment post-biopsy and 5 patients received mastectomy. No recurrences were noted. 3/13 cases of benign AME had associated breast malignancies including invasive ductal adenocarcinoma and ductal carcinoma in-situ. 1 case of malignant AME had a synchronous separate malignant phyllodes tumor. Given the unclear and unpredictable propensity for malignant transformation, conservative excision with negative margins currently seems appropriate.",
keywords = "Adenomyoepithelioma, Adenomyoepithelioma with carcinoma, AME, Malignant adenomyoepithelioma, Malignant transformation of adenomyoepithelioma, Radiology of adenomyoepithelioma",
author = "Moritz, {August W.} and Wiedenhoefer, {James F.} and Profit, {Amanda P.} and Jaishree Jagirdar",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.breast.2016.07.018",
language = "English (US)",
volume = "29",
pages = "132--139",
journal = "Breast",
issn = "0960-9776",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Breast adenomyoepithelioma and adenomyoepithelioma with carcinoma (malignant adenomyoepithelioma) with associated breast malignancies

T2 - A case series emphasizing histologic, radiologic, and clinical correlation

AU - Moritz, August W.

AU - Wiedenhoefer, James F.

AU - Profit, Amanda P.

AU - Jagirdar, Jaishree

PY - 2016/10/1

Y1 - 2016/10/1

N2 - The 2012 World Health Organization (WHO) classification of breast tumors distinguishes adenomyoepitheliomas (AMEs) as benign tumors composed of a biphasic proliferation of phenotypically variable myoepithelial cells around small epithelial lined spaces. Many AMEs have demonstrated benign behavior and are often cured with excision with negative margins, but some have exhibited malignant transformation of the myoepithelial cells, ductal epithelial cells, or both. When one of the components is histologically malignant, it is termed AME with carcinoma. Due to the rarity, the literature correlating imaging, histology, and clinical outcome is limited. A retrospective review was undertaken. A review of an institutional pathology database identified 14 cases with AME or malignant AME. Most AMEs had nonspecific imaging findings and were categorized as Bi-Rads 4. Histologic features of AME did not correlate with prior or concurrent breast malignancies or any radiographic features. Clinical follow up could be obtained for all but one case (mean follow up time = 75 months). 5 cases had no known treatment post-biopsy and 5 patients received mastectomy. No recurrences were noted. 3/13 cases of benign AME had associated breast malignancies including invasive ductal adenocarcinoma and ductal carcinoma in-situ. 1 case of malignant AME had a synchronous separate malignant phyllodes tumor. Given the unclear and unpredictable propensity for malignant transformation, conservative excision with negative margins currently seems appropriate.

AB - The 2012 World Health Organization (WHO) classification of breast tumors distinguishes adenomyoepitheliomas (AMEs) as benign tumors composed of a biphasic proliferation of phenotypically variable myoepithelial cells around small epithelial lined spaces. Many AMEs have demonstrated benign behavior and are often cured with excision with negative margins, but some have exhibited malignant transformation of the myoepithelial cells, ductal epithelial cells, or both. When one of the components is histologically malignant, it is termed AME with carcinoma. Due to the rarity, the literature correlating imaging, histology, and clinical outcome is limited. A retrospective review was undertaken. A review of an institutional pathology database identified 14 cases with AME or malignant AME. Most AMEs had nonspecific imaging findings and were categorized as Bi-Rads 4. Histologic features of AME did not correlate with prior or concurrent breast malignancies or any radiographic features. Clinical follow up could be obtained for all but one case (mean follow up time = 75 months). 5 cases had no known treatment post-biopsy and 5 patients received mastectomy. No recurrences were noted. 3/13 cases of benign AME had associated breast malignancies including invasive ductal adenocarcinoma and ductal carcinoma in-situ. 1 case of malignant AME had a synchronous separate malignant phyllodes tumor. Given the unclear and unpredictable propensity for malignant transformation, conservative excision with negative margins currently seems appropriate.

KW - Adenomyoepithelioma

KW - Adenomyoepithelioma with carcinoma

KW - AME

KW - Malignant adenomyoepithelioma

KW - Malignant transformation of adenomyoepithelioma

KW - Radiology of adenomyoepithelioma

UR - http://www.scopus.com/inward/record.url?scp=84980398324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84980398324&partnerID=8YFLogxK

U2 - 10.1016/j.breast.2016.07.018

DO - 10.1016/j.breast.2016.07.018

M3 - Article

C2 - 27494340

AN - SCOPUS:84980398324

VL - 29

SP - 132

EP - 139

JO - Breast

JF - Breast

SN - 0960-9776

ER -